Camp4 Therapeutics reported total assets of $93.43M and total liabilities of $94.12M for the quarter ended Jun 2026, up 82.2% year over year. This balance sheet covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash & EquivalentsCash & Equiv. | 50.47M | 38.38M | 2.53M | 64.04M | 49.32M | 39.10M | 75.30M | 109.52M | 99.21M | 86.40M | ||
| Receivables - NetNet Receivables | 1.00M | 0.30M | 0.40M | |||||||||
| Receivables - OtherOther Receivables | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.15M | ||||||
| Receivables | 1.10M | 0.40M | 0.40M | |||||||||
| Prepaid Assets | 1.63M | 1.98M | 2.34M | 2.35M | 2.03M | 2.45M | 3.23M | 2.26M | 2.90M | |||
| Current Assets | 40.01M | 5.50M | 66.38M | 51.67M | 41.09M | 77.71M | 114.09M | 102.20M | 90.03M | |||
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment (Net) | 4.80M | 3.86M | 3.60M | 3.41M | 2.90M | 2.34M | 1.93M | 1.85M | ||||
| Other Non-Current Assets | 1.62M | 1.62M | 3.32M | 1.62M | 1.62M | 1.62M | 1.62M | 2.20M | 1.60M | 1.60M | ||
| Non-Current Assets | 14.93M | 15.86M | 11.92M | 11.10M | 10.19M | 8.69M | 3.71M | 3.26M | 3.40M | |||
| Assets | 54.95M | 21.36M | 78.31M | 62.77M | 51.27M | 86.39M | 117.81M | 105.46M | 93.43M | |||
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payables | 1.04M | 3.87M | 1.21M | 1.40M | 1.20M | 0.58M | 0.18M | 0.86M | 1.09M | |||
| Payables | 1.04M | 3.87M | 1.21M | 1.40M | 1.20M | 0.58M | 0.18M | 0.86M | 1.09M | |||
| Accumulated Expenses | 3.30M | 3.68M | 4.83M | 1.84M | 2.87M | 4.07M | 5.66M | 4.30M | 4.24M | |||
| Other Accumulated Expenses | 0.29M | 0.37M | 0.18M | 0.03M | ||||||||
| Current Leases | 2.70M | 2.92M | 2.99M | 3.07M | 3.15M | 3.23M | 0.29M | 0.38M | 0.80M | |||
| Current Deferred Revenue | 1.00M | 0.39M | 9.39M | 11.07M | 13.01M | |||||||
| Total Current Liabilities | 7.81M | 11.83M | 9.60M | 6.44M | 7.33M | 7.90M | 15.51M | 16.62M | 19.14M | |||
| Non-Current Liabilities | ||||||||||||
| Capital Leases | 0.15M | 0.09M | 0.07M | 0.06M | 0.06M | 0.05M | ||||||
| Non-Current Deffered Revenue | 8.11M | 5.21M | 1.50M | |||||||||
| Preferred Stock Liabilities | 162.15M | 162.15M | 162.15M | 162.15M | 162.15M | |||||||
| Operating Leases | 8.49M | 6.27M | 5.49M | 7.77M | 7.04M | 6.27M | 1.69M | 2.12M | 2.37M | |||
| Other Non-Current Liabilities | 0.00M | 0.00M | 0.07M | 0.00M | 0.00M | 16.73M | 44.76M | 50.95M | 71.88M | |||
| Total Non-Current Liabilities | 16.53M | 18.19M | 15.09M | 11.20M | 11.29M | 11.00M | 25.34M | 23.61M | 22.24M | |||
| Total Liabilities | 111.55M | 16.53M | 135.33M | 147.11M | 18.19M | 15.16M | 11.20M | 11.29M | 27.73M | 70.10M | 74.56M | 94.12M |
| Shareholder's Equity | ||||||||||||
| Common Equity | -111.55M | -123.73M | -135.33M | -147.11M | -158.97M | 63.14M | 51.57M | 39.99M | 58.67M | 47.70M | 30.90M | -0.69M |
| Liabilities and Shareholders Equity | 54.95M | 21.36M | 78.31M | 62.77M | 51.27M | 86.39M | 117.81M | 105.46M | 93.43M | |||
| Retained Earnings | -159.96M | -198.50M | 274.89M | 275.76M | 276.76M | 310.53M | 339.85M | 341.38M | -344.02M | |||
| Treasury Shares | 130.65M | 130.65M | 130.65M | 130.65M | 130.65M |